The ability of GSDME to augment apoptosis by targeting and permeabilizing the mitochondria suggests that it functions in a manner analogous to proapoptotic Bcl-2 family members1,3, which might explain its putative tumor suppressive activity. Here, BCL2 is linked to neoplasm.